TMS motor mapping in brain tumor patients: more robust maps with an increased resting motor threshold.


Journal

Acta neurochirurgica
ISSN: 0942-0940
Titre abrégé: Acta Neurochir (Wien)
Pays: Austria
ID NLM: 0151000

Informations de publication

Date de publication:
05 2019
Historique:
received: 12 12 2018
accepted: 20 03 2019
pubmed: 31 3 2019
medline: 7 3 2020
entrez: 31 3 2019
Statut: ppublish

Résumé

Navigated transcranial magnetic stimulation (nTMS) has found widespread usage across many clinical centers as part of their surgical planning routines. NTMS offers a non-invasive approach to delineation of the motor cortex, in which the region is outlined through electromagnetic stimulation and electromyographic recordings of target muscles. Several neurophysiological parameters such as the motor evoked potential (MEP) and its derivatives, the resting motor threshold (RMT) and motor latency, are collected. The present study investigates the clinical feasibility and reproducibility of increasing the MEP threshold in brain tumor patients, with the goal to improve the robustness of the procedure. Twenty-three subjects with peri-motor cortex tumors underwent motor mapping with nTMS. RMT was calculated with both conventional 50-μV and experimental 500-μV MEP amplitude thresholds. Motor mapping was performed with 105% of both RMTs stimulator intensity using the FDI as the target muscle. Motor mapping was possible in 20 patients with both the conventional and experimental thresholds. No significant differences in area size were found between motor area maps generated with a conventional 50-μV threshold in comparison to those generated with the higher 500-μV threshold (50 μV 272.56 mm Our study demonstrates the feasibility of increasing the MEP detection threshold to 500 μV in brain tumor patients for RMT determination and motor area mapping with nTMS.

Identifiants

pubmed: 30927156
doi: 10.1007/s00701-019-03883-8
pii: 10.1007/s00701-019-03883-8
doi:

Types de publication

Evaluation Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

995-1002

Subventions

Organisme : Instituto de Salud Carlos III
ID : CM/00016
Pays : International

Auteurs

Steven Lam (S)

Department of Neurosurgery, Charité Universitätsmedizin Berlin, Berlin, Germany.

Giuseppe Lucente (G)

Neuroscience Department, Hospital Universitari Germans Trias I Pujol, Carretera del Canyet s/n, 08916, Badalona, Spain. glucente@igtp.cat.
Medicine Department, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain. glucente@igtp.cat.

Heike Schneider (H)

Department of Neurosurgery, Charité Universitätsmedizin Berlin, Berlin, Germany.

Thomas Picht (T)

Department of Neurosurgery, Charité Universitätsmedizin Berlin, Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH